Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: TPL reduces leverage when agreeing to these extensions.
Reply New Message
Prev Message Back To Forum Threaded View Next Message

"The 336' is done - why else would TPL release that PR regarding the 336'"

Right!! Wouldn't they be in HOT h2o if they PR'd a lie and continued to sign infringers?

This is just another incredible buying opportunity IMO

6 Recommendations
Reply New Message
Prev Message Back To Forum Threaded View Next Message
Share
Share
New Message
Please login to post a reply